Mercado de terapias de proteínas: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00002856
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

La terapia proteica suministra proteínas al cuerpo en cantidades precisas (según las necesidades del paciente), para tratar diversas afecciones médicas como diabetes, anemia, insuficiencia renal crónica o rehacer estructuras. Las proteínas terapéuticas son medicamentos potentes y de acción rápida que han demostrado ser muy eficaces en el tratamiento de una amplia gama de enfermedades. A medida que se comprendan mejor los mecanismos moleculares de las enfermedades, seguirán existiendo oportunidades para desarrollar terapias proteicas. El campo de la terapéutica proteica se ha desarrollado significativamente desde 1982, desde la introducción de la primera proteína de insulina humana derivada de ADN recombinante. Las proteínas tienen varias ventajas sobre los medicamentos de moléculas pequeñas que actualmente dominan el mercado farmacéutico.

El creciente enfoque en el desarrollo de productos terapéuticos proteicos, las innovaciones continuas en medicamentos de proteínas recombinantes y los crecientes medicamentos basados en anticuerpos han llevado a una mayor investigación sobre Ingeniería de proteínas. También se ha identificado que las proteínas y péptidos terapéuticos tienen un gran potencial para el tratamiento de diversas enfermedades como cánceres, enfermedades neurodegenerativas y otras. Sin embargo, es probable que la inestabilidad fisicoquímica de las proteínas y las preocupaciones sobre la inmunogenicidad limiten el mercado global de terapias de proteínas durante el período de pronóstico.

El "Análisis del mercado global de terapias de proteínas hasta 2031" es un estudio especializado y en profundidad de la industria de la biotecnología con un enfoque en la tendencia del mercado global. El informe tiene como objetivo proporcionar una visión general del mercado global con una segmentación detallada del mercado por producto, aplicación, usuario final y geografía. Se espera que el mercado mundial de terapias de proteínas sea testigo de un alto crecimiento durante el período de pronóstico. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado de Terapéutica de proteínas y ofrece tendencias y oportunidades clave en el mercado.

El mercado mundial de Terapéutica de proteínas está segmentado según el producto, la aplicación y el fin. usuario. Según el producto, el mercado se segmenta en anticuerpos monoclonales, insulina, proteína de fusión, eritropoyetina, interferón, hormona del crecimiento humano y hormona folículo estimulante. El mercado de terapias proteicas por aplicación se clasifica en trastornos metabólicos, trastornos inmunológicos, trastornos hematológicos, cáncer, trastornos hormonales, trastornos genéticos y otros. Según el usuario final, el mercado de terapias proteicas se clasifica en compañías farmacéuticas, proveedores de servicios de atención médica, organizaciones de investigación y empresas. institutos de investigación académica.

El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y un pronóstico del producto, la aplicación y el usuario final del mercado global de terapias de proteínas. También proporciona el tamaño del mercado y el pronóstico hasta 2031 para el mercado general con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y Sur y África. Centroamérica. El mercado terapéutico de proteínas de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 13 países a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región.

América del Norte mantuvo la participación dominante en el mercado de terapias proteicas en 2021. La mayor parte se atribuye a los avances tecnológicos. , las políticas de reembolso favorables, el desarrollo de productos novedosos y la mejora del nivel de vida han llevado a un aumento de la esperanza de vida, lo que ha contribuido al aumento de la población geriátrica. Estos factores están impulsando el crecimiento de las terapias proteicas en esta región.
Se espera que la región de Asia y el Pacífico muestre la CAGR más alta durante el período previsto debido a la alta prevalencia de enfermedades crónicas como la diabetes. Además, la creciente industria del turismo médico en la región de Asia Pacífico también es un factor importante que se prevé impulsará la demanda del mercado de terapias proteicas durante el período de pronóstico. Además, se prevé que factores como la creciente demanda de opciones de tratamiento avanzadas, las economías emergentes como China, India y Japón y el aumento del ingreso per cápita creen vías de crecimiento para los actores del mercado en Asia Pacífico durante el período previsto.

El informe analiza los factores que afectan el mercado de Terapéutica de proteínas tanto desde el lado de la demanda como de la oferta y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y Sur y Sur. Centroamérica después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de Proteínas Terapéuticas en estas regiones.

El informe también incluye los perfiles de empresas clave de Proteínas Terapéuticas junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años y desarrollos clave en los últimos cinco años. Algunos de los actores clave que operan en el mercado de Terapéutica de proteínas incluyen Novo Nordisk A/S, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Amgen Inc., AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Kyowa Hakko Kirin Co., Ltd., Pfizer Inc. y F. Hoffmann-La Roche Ltd, entre otros.

.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the deliverable formats of the Protein Therapeutics Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are key players in Protein Therapeutics Market?

Key companies in this market are - Novo Nordisk A/S, Janssen Global Services LLC, Johnson & Johnson Services Inc, Amgen Inc, AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Kyowa Hakko Kirin Co Ltd, Pfizer Inc

What are future trends in the Protein Therapeutics market?

The Protein Therapeutics Market is expected to witness a shift towards personalised medicine with enormous focus on tailored therapy. Innovative therapeutic proteins, better drug design and advancement in protein engineering would deliver enhanced efficacy, addressing specific patient need and expanding market applications.

What is expected CAGR in the Protein Therapeutics Market?

The market is expected to register a CAGR of 6.5% during 2023-2031

What are factors impacting on the Protein Therapeutics market?

Fueling the growth of the Protein Therapeutics Market is the rising incidence of chronic diseases, and the growing need for biologic therapeutics. Also, the rising demand for protein-based therapies is due to the rising acceptance of biological therapies, global efforts to cure chronic diseases, and scientific advancements in protein engineering and manufacturing.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Novo Nordisk A/S
2. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
3. Amgen Inc.
4. AstraZeneca
5. Baxter
6. Boehringer Ingelheim International GmbH
7. Teva Pharmaceutical Industries Ltd.
8. Kyowa Hakko Kirin Co., Ltd.
9. Pfizer Inc.
10. F. Hoffmann-La Roche Ltd

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.